70 years old, as assessed by the dual-energy x-ray absorptiometry (DEXA) technique and the decrease of osteoclastic activity. A significant increase in most libido parameters was also found in these older women. Improvement of the skin status was observed, particularly in women, in terms of hydration, epidermal thickness, sebum production, and pigmentation. A number of biological indices confirmed the lack of harmful consequences of this 50 mg/day DHEA administration over one year, also indicating that this kind of replacement therapy normalized some effects of aging, but does not create "supermen/women" (doping)." />
Display options
Cite
Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000;97(8):4279-84doi: 10.1073/pnas.97.8.4279.
Baulieu, E. E., Thomas, G., Legrain, S., Lahlou, N., Roger, M., Debuire, B., Faucounau, V., Girard, L., Hervy, M. P., Latour, F., Leaud, M. C., Mokrane, A., Pitti-Ferrandi, H., Trivalle, C., de Lacharrière, O., Nouveau, S., Rakoto-Arison, B., Souberbielle, J. C., Raison, J., Le Bouc, Y., Raynaud, A., Girerd, X., & Forette, F. (2000). Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proceedings of the National Academy of Sciences of the United States of America, 97(8), 4279-84. https://doi.org/10.1073/pnas.97.8.4279
Baulieu, E E, et al. "Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue." Proceedings of the National Academy of Sciences of the United States of America vol. 97,8 (2000): 4279-84. doi: https://doi.org/10.1073/pnas.97.8.4279
Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4279-84. doi: 10.1073/pnas.97.8.4279. PMID: 10760294; PMCID: PMC18228.
Copy Download .nbib Format: NLM
Share it on

Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4279-84. doi: 10.1073/pnas.97.8.4279.

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue.

Proceedings of the National Academy of Sciences of the United States of America

E E Baulieu, G Thomas, S Legrain, N Lahlou, M Roger, B Debuire, V Faucounau, L Girard, M P Hervy, F Latour, M C Leaud, A Mokrane, H Pitti-Ferrandi, C Trivalle, O de Lacharrière, S Nouveau, B Rakoto-Arison, J C Souberbielle, J Raison, Y Le Bouc, A Raynaud, X Girerd, F Forette

Affiliations

  1. Institut National de la Santé et de la Recherche Médicale Unit 488 and Collège de France, 94276 Le Kremlin-Bicêtre, France. [email protected]

PMID: 10760294 PMCID: PMC18228 DOI: 10.1073/pnas.97.8.4279

Abstract

The secretion and the blood levels of the adrenal steroid dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) decrease profoundly with age, and the question is posed whether administration of the steroid to compensate for the decline counteracts defects associated with aging. The commercial availability of DHEA outside the regular pharmaceutical-medical network in the United States creates a real public health problem that may be resolved only by appropriate long-term clinical trials in elderly men and women. Two hundred and eighty healthy individuals (women and men 60-79 years old) were given DHEA, 50 mg, or placebo, orally, daily for a year in a double-blind, placebo-controlled study. No potentially harmful accumulation of DHEAS and active steroids was recorded. Besides the reestablishment of a "young" concentration of DHEAS, a small increase of testosterone and estradiol was noted, particularly in women, and may be involved in the significantly demonstrated physiological-clinical manifestations here reported. Bone turnover improved selectively in women >70 years old, as assessed by the dual-energy x-ray absorptiometry (DEXA) technique and the decrease of osteoclastic activity. A significant increase in most libido parameters was also found in these older women. Improvement of the skin status was observed, particularly in women, in terms of hydration, epidermal thickness, sebum production, and pigmentation. A number of biological indices confirmed the lack of harmful consequences of this 50 mg/day DHEA administration over one year, also indicating that this kind of replacement therapy normalized some effects of aging, but does not create "supermen/women" (doping).

References

  1. J Clin Endocrinol Metab. 1999 May;84(5):1527-33 - PubMed
  2. Endocrine. 1999 Aug;11(1):1-11 - PubMed
  3. Dermatologica. 1988;177(6):332-7 - PubMed
  4. Maturitas. 1980 Oct;2(3):171-7 - PubMed
  5. N Engl J Med. 1999 Sep 30;341(14):1013-20 - PubMed
  6. Clin Chem. 1998 Nov;44(11):2290-300 - PubMed
  7. J Bone Miner Res. 1994 Feb;9(2):255-64 - PubMed
  8. Ann N Y Acad Sci. 1995 Dec 29;774:121-7 - PubMed
  9. J Clin Endocrinol Metab. 1957 Sep;17(9):1051-62 - PubMed
  10. J Clin Endocrinol Metab. 1996 Sep;81(9):3147-51 - PubMed
  11. J Am Geriatr Soc. 1990 Apr;38(4):421-7 - PubMed
  12. J Clin Endocrinol Metab. 1994 Jun;78(6):1360-7 - PubMed
  13. J Clin Endocrinol Metab. 1984 Sep;59(3):551-5 - PubMed
  14. J Clin Endocrinol Metab. 1996 Mar;81(3):1173-8 - PubMed
  15. Photodermatol Photoimmunol Photomed. 1990 Feb;7(1):20-4 - PubMed
  16. J Bone Miner Res. 1996 Oct;11(10):1531-8 - PubMed
  17. Fertil Steril. 1998 Jul;70(1):107-10 - PubMed
  18. J Endocrinol. 1996 Sep;150 Suppl:S43-50 - PubMed
  19. Recent Prog Horm Res. 1965;21:411-500 - PubMed
  20. J Clin Endocrinol Metab. 1997 Aug;82(8):2396-402 - PubMed
  21. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13410-5 - PubMed

Substances

MeSH terms

Publication Types